• Novel Therapeutics for serious endocrine-mediated diseases

About Radius


Radius is a science-driven biopharmaceutical company focused on developing new therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases.

Read More

Recent News

Focus On


Our lead investigational drug product candidate in clinical trials has been designed with the objective of building new bone in patients with osteoporosis, with the goal, if demonstrated in clinical trials, of reducing the risk of future fractures and improving the quality of life.

Read More